LMP Capital & Income Fund(SCD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SCD LMP Capital & Income Fund

盘后交易 09-15 17:51:47 EDT

15.19

-0.14

-0.91%

盘后15.19

+0.000.00%

16:10 EDT

最高15.43	最低15.19	成交量4.85万
今开15.35	昨收15.33	日振幅1.57%
总市值3.47亿	流通市值3.47亿	总股本2,286万
成交额74.08万	换手率0.21%	流通股本2,286万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SCD","market":"US","secType":"STK","nameCN":"LMP Capital & Income Fund","latestPrice":15.19,"timestamp":1789502400000,"preClose":15.33,"halted":0,"volume":48483,"hourTrading":{"tag":"盘后","latestPrice":15.19,"preClose":15.19,"latestTime":"16:10 EDT","volume":6551,"amount":99509.69,"timestamp":1789503007544,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009132420091324239,"floatShares":22857660,"shares":22857660,"eps":2.80735,"marketStatus":"盘后交易","change":-0.14,"latestTime":"09-15 17:51:47 EDT","open":15.35,"high":15.43,"low":15.19,"amount":740791,"amplitude":0.015656,"askPrice":15.93,"askSize":330,"bidPrice":14.89,"bidSize":50,"shortable":3,"etf":0,"ttmEps":2.80735,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":15.33,"dividendRate":0.094832,"preHourTrading":{"tag":"盘前","latestPrice":15.33,"preClose":15.33,"latestTime":"08:05 EDT","volume":1,"amount":15.33,"timestamp":1789473917064,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":15.19,"preClose":15.19,"latestTime":"16:10 EDT","volume":6551,"amount":99509.69,"timestamp":1789503007544,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.62723},"requestUrl":"/m/hq/s/SCD/","defaultTab":"news","newsList":[{"id":"1182566662","title":"Fulcrum Therapeutics任命Josh Lehrer加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1182566662","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182566662?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:58","pubTimestamp":1777287509,"startTime":"0","endTime":"0","summary":"马萨诸塞州剑桥，2026年4月27日——临床阶段生物制药公司Fulcrum Therapeutics今日宣布，任命医学博士、哲学硕士、美国心脏病学院院士Josh Lehrer为其董事会独立董事。他现任临床阶段生物技术公司Marea Therapeutics的首席执行官兼董事会成员。Fulcrum Therapeutics是一家临床阶段生物制药公司，致力于研发改善罕见血液疾病患者生活的小分子药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","FULC","R","BK4232","BK4007","SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514673780","title":"Biotech众生相：蓝鸟生物以最高1亿美元被收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2514673780","media":"国际金融报","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514673780?lang=zh_cn&edition=full","pubTime":"2025-02-25 19:13","pubTimestamp":1740482032,"startTime":"0","endTime":"0","summary":"上市后，蓝鸟生物股价一路高歌猛进，市值一度逼近300亿美元。截至去年第三季度，蓝鸟生物去年实现营收4528.6万美元，亏损2.12亿美元。果不其然，蓝鸟生物在今年2月宣布“卖身”，但最高1亿美元的价格还是让市场为之震惊。两项合计，此次交易的最高潜在金额约为1亿美元。Biotech众生相在被收购前，蓝鸟生物也曾采取过一系列措施“自救”。其中普方生物的交易金额创下新高，总金额高达130亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225191403962fc16a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225191403962fc16a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BMS","BK4139","BK4578","BLUE","SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492930566","title":"日本国立材料研究所廖梅勇团队实现金刚石DUV探测器低电压高增益新突破！","url":"https://stock-news.laohu8.com/highlight/detail?id=2492930566","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492930566?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:45","pubTimestamp":1734432300,"startTime":"0","endTime":"0","summary":"金刚石作为一种具有超宽带隙、高热导率、化学惰性、高绝缘性和辐射抗性的材料，被认为是制造DUV光电探测器的理想候选材料。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-17/doc-inczukxm4793002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PD","SCD","PMT","BK4110","BK4023","LU1169589451.USD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481915989","title":"Lmp Capital And Income Fund Inc.盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481915989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481915989?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:44","pubTimestamp":1730904291,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时44分，Lmp Capital And Income Fund Inc.股票出现波动，股价大幅上涨5.73%。Lmp Capital And Income Fund Inc.股票所在的资产管理行业中，整体涨幅为2.43%。Lmp Capital And Income Fund Inc.公司简介：Lmp Capital & Income Fund Inc 是一家总部位于美国的非多元化、封闭式管理投资公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622445198e40e6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622445198e40e6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2470047346","title":"再裁员1/4！市值从百亿到1亿，跌去99%后，明星Biotech“挥刀”续命","url":"https://stock-news.laohu8.com/highlight/detail?id=2470047346","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2470047346?lang=zh_cn&edition=full","pubTime":"2024-09-28 21:12","pubTimestamp":1727529121,"startTime":"0","endTime":"0","summary":"没钱，往往能遏住绝大多数Biotech脖子。撰文| Qsher一则裁员重组消息，再次将明星Biotech蓝鸟生物推至聚光灯下。截至6月底，蓝鸟生物拥有375名全职员工，此次裁员意味着将有近百名员工离开。截至今年6月底，蓝鸟生物仅有约1.93亿美元的现金余额，其中包括4900万美元的限制性现金。此番，通过裁员重组，通过“续命丹丸”将延长至2025下半年。明星Biotech的陨落与自救伴随着产品上市，在商业化上逐渐凸显的困境，让蓝鸟生物看见了市场的残酷性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409282121239583d44a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409282121239583d44a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCD","BK4578","BK4556","BK4139","BLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179497928","title":"Fulcrum Therapeutics洛司马匹德三期临床试验失利，股价重挫逾60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497928","media":"华尔街洞察","labels":["analysis"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179497928?lang=zh_cn&edition=full","pubTime":"2024-09-13 08:20","pubTimestamp":1726186800,"startTime":"0","endTime":"0","summary":"纳斯达克上市公司$Fulcrum Therapeutics$, Inc.今日股价暴跌超过60%,主要原因是其主导候选药物洛司马匹德未能在治疗肌肉营养不良症的关键三期临床试验REACH中达到预期目标。根据Fulcrum发布的声明,REACH试验未能达到评估肌肉力量恢复的主要终点指标,次要终点指标也未达到显著性水平。Fulcrum CEO Alex C. Sapir表示,鉴于这些不利结果,公司将暂停洛司马匹德在FSHD适应证的进一步开发。这对Fulcrum无疑是一个重大打击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","03347","RNA","03165","LU0234570918.USD","LU1883839398.USD","BK4556","LU0889565916.HKD","LU1066053197.SGD","LU2456880835.USD","CRSP","LU0170899867.USD","IE00BKVL7J92.USD","LU1861558580.USD","BK4552","LU0070302665.USD","MFI","SGXZ57979304.SGD","BK4207","SCD","LU2462157665.USD","LU1366192091.USD","BK4568","BK1576","LU0648001328.SGD","LU1668664300.SGD","VRTX","BLUE","BK1583","BK4127","IE00B2B36J28.USD","LU2237443978.SGD","SNY","BK1141","LU1093756168.USD","RHHBY","BK4139","BK4550","BK4007","LU0130102774.USD","IE00BJJMRZ35.SGD","BK4505","LU0079474960.USD","LU1201861165.SGD","LENZ","LU0208291251.USD","LU2237443465.HKD","LU2237443549.SGD","FULC","BK4581","LU1093756325.SGD","BAC","LU1718418525.SGD","LU2237443622.USD","PRO","IE00BFTCPJ56.SGD","PFE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.franklintempleton.com","stockEarnings":[{"period":"1week","weight":-0.0179},{"period":"1month","weight":-0.0328},{"period":"3month","weight":-0.0186},{"period":"6month","weight":0.0213},{"period":"1year","weight":-0.0211},{"period":"ytd","weight":0.0351}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lmp Capital & Income Fund Inc.于2003年11月12日在马里兰州注册成立，并根据1940年修订的《投资公司法》（\"1940年法案\"）注册为非多元化封闭式管理投资公司。该基金的投资目标是总回报，强调收入。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.013084},{"month":2,"riseRate":0.590909,"avgChangeRate":-0.003757},{"month":3,"riseRate":0.478261,"avgChangeRate":-0.01356},{"month":4,"riseRate":0.652174,"avgChangeRate":0.015315},{"month":5,"riseRate":0.608696,"avgChangeRate":0.008137},{"month":6,"riseRate":0.434783,"avgChangeRate":-0.007639},{"month":7,"riseRate":0.565217,"avgChangeRate":0.010599},{"month":8,"riseRate":0.652174,"avgChangeRate":0.008574},{"month":9,"riseRate":0.391304,"avgChangeRate":-0.022584},{"month":10,"riseRate":0.409091,"avgChangeRate":-0.012605},{"month":11,"riseRate":0.590909,"avgChangeRate":0.010643},{"month":12,"riseRate":0.636364,"avgChangeRate":0.005706}],"exchange":"NYSE","name":"LMP Capital & Income Fund","nameEN":"LMP Capital and Income Fund Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LMP Capital & Income Fund(SCD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LMP Capital & Income Fund(SCD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LMP Capital & Income Fund,SCD,LMP Capital & Income Fund股票,LMP Capital & Income Fund股票老虎,LMP Capital & Income Fund股票老虎国际,LMP Capital & Income Fund行情,LMP Capital & Income Fund股票行情,LMP Capital & Income Fund股价,LMP Capital & Income Fund股市,LMP Capital & Income Fund股票价格,LMP Capital & Income Fund股票交易,LMP Capital & Income Fund股票购买,LMP Capital & Income Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LMP Capital & Income Fund(SCD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LMP Capital & Income Fund(SCD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}